Back to search

Article

Lenvatinib Inhibits Intrahepatic Cholangiocarcinoma Growth via Gadd45a-Mediated Cell Cycle Arrest

2021-09-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer, and its 5-year survival rate is less than 10%. Fibroblast growth factor receptor (FGFR) changes have been observed in 6%-50% of ICC patients, and patients with FGFR mutations have been shown to have more inert tumour biological activity than patients with wild-type FGFRs. Thus,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f72463a-a6e3-5504-a425-9410dc98522a
DOI
10.21203/rs.3.rs-885590/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lenvatinib Inhibits Intrahepatic Cholangiocarcinoma Growth via Gadd45a-Mediated Cell Cycle ArrestDOI 10.21203/rs.3.rs-885590/v1
Select a neighboring publication to make it the new centre.